Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CURO Group Holdings Corp. stock logo
CURO
CURO Group
$0.04
$0.04
$0.04
$2.25
$1.69M2.21984,281 shsN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
$1.50
-2.6%
$1.35
$1.02
$5.52
$6.10M2.68941,821 shs87,991 shs
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
$0.65
-7.2%
$1.19
$2.08
$5.30
$5.60M-0.2651,114 shs234,233 shs
SHF Holdings, Inc. stock logo
SHFS
SHF
$2.24
-5.1%
$3.60
$1.84
$15.84
$6.24M0.59195,493 shs18,386 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CURO Group Holdings Corp. stock logo
CURO
CURO Group
0.00%0.00%0.00%0.00%-25.45%
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
-2.60%-18.39%+21.95%-25.15%-47.18%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
-7.24%-12.23%-55.17%-62.43%-84.18%
SHF Holdings, Inc. stock logo
SHFS
SHF
-5.08%-12.16%+4.67%-72.07%-85.45%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CURO Group Holdings Corp. stock logo
CURO
CURO Group
N/AN/AN/AN/AN/AN/AN/AN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
1.1912 of 5 stars
0.04.00.00.02.71.70.6
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
SHF Holdings, Inc. stock logo
SHFS
SHF
1.7402 of 5 stars
0.05.00.00.03.80.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CURO Group Holdings Corp. stock logo
CURO
CURO Group
0.00
N/AN/AN/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
0.00
N/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
0.00
N/AN/AN/A
SHF Holdings, Inc. stock logo
SHFS
SHF
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CURO Group Holdings Corp. stock logo
CURO
CURO Group
$418.33M0.00$2.05 per share0.02($1.34) per share-0.03
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
$12.78M0.48N/AN/A$3.39 per share0.44
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/A$1.50 per shareN/A
SHF Holdings, Inc. stock logo
SHFS
SHF
$17.87M0.35$0.11 per share21.07$0.63 per share3.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CURO Group Holdings Corp. stock logo
CURO
CURO Group
-$266.73M-$6.49N/AN/AN/A-35.34%N/A-8.23%N/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
-$60KN/A0.00N/AN/AN/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%N/A
SHF Holdings, Inc. stock logo
SHFS
SHF
-$17.28M$3.4013.18N/A36.34%10.24%5.66%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CURO Group Holdings Corp. stock logo
CURO
CURO Group
$0.441,073.17%N/AN/A N/A
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
N/AN/AN/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/AN/A
SHF Holdings, Inc. stock logo
SHFS
SHF
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CURO Group Holdings Corp. stock logo
CURO
CURO Group
N/A
9.33
9.33
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
N/A
56.75
N/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/A
2.41
2.41
SHF Holdings, Inc. stock logo
SHFS
SHF
0.22
0.83
0.83

Institutional Ownership

CompanyInstitutional Ownership
CURO Group Holdings Corp. stock logo
CURO
CURO Group
39.87%
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
0.51%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
1.37%
SHF Holdings, Inc. stock logo
SHFS
SHF
29.19%

Insider Ownership

CompanyInsider Ownership
CURO Group Holdings Corp. stock logo
CURO
CURO Group
26.12%
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
63.02%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
1.05%
SHF Holdings, Inc. stock logo
SHFS
SHF
7.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
CURO Group Holdings Corp. stock logo
CURO
CURO Group
5,20041.30 million30.51 millionOptionable
Magic Empire Global Limited stock logo
MEGL
Magic Empire Global
84.06 million1.50 millionNot Optionable
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
108.62 million8.53 millionNot Optionable
SHF Holdings, Inc. stock logo
SHFS
SHF
32.78 million22.01 millionNot Optionable

Recent News About These Companies

Why SHF Holdings, Inc. (SHFS) Soared on Monday
Why SHF Holdings, Inc. (SHFS) Soared on Monday
SHF Holdings announces strategic partnership with FundCanna
SHF Holdings reports FY24 EPS ($17.43) vs. ($8.12) last year
SHF Holdings Inc trading halted, news pending
SHF Holdings appoints Mike Regan as head, IR and data science
SHF Holdings approves reverse stock split
SHF Holdings issues letter to shareholders

New MarketBeat Followers Over Time

Media Sentiment Over Time

CURO Group stock logo

CURO Group NYSE:CURO

CURO Group Holdings Corp., together with its subsidiaries, provides consumer finance products in the United States and Canada. The company offers secured and unsecured installment loans, revolving line of credit, and single-pay loans; and credit protection insurance, check cashing, money transfer, foreign currency exchange, and other ancillary financial products and services, as well as reloadable prepaid debit cards and demand deposit accounts. The company also provides loans through online. It operates under the Covington Credit, Heights Finance, Quick Credit, Southern Finance, First Heritage Credit, Cash Money, LendDirect, and Flexiti brands. The company was formerly known as Speedy Group Holdings Corp. and changed its name to CURO Group Holdings Corp. in May 2016. CURO Group Holdings Corp. was founded in 1997 and is headquartered in Chicago, Illinois.

Magic Empire Global stock logo

Magic Empire Global NASDAQ:MEGL

$1.50 -0.04 (-2.60%)
As of 05/14/2025 04:00 PM Eastern

Magic Empire Global Limited engages in the provision of corporate finance advisory services and underwriting services in Hong Kong. The company provides initial public offering sponsorship, financial and independent financial advisory, post-listing compliance advisory, and underwriting services by acting as global coordinator, bookrunner, lead manager, or underwriter. It also offers corporate services, which include accounting and financial reporting advisory, company secretarial services, internal control enhancement, investor relations advisory, and other consulting services. The company was incorporated in 2016 and is headquartered in Central, Hong Kong.

NeuroBo Pharmaceuticals stock logo

NeuroBo Pharmaceuticals NASDAQ:NRBO

$0.65 -0.05 (-7.24%)
As of 05/13/2025

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

SHF stock logo

SHF NASDAQ:SHFS

$2.24 -0.12 (-5.08%)
As of 05/14/2025 04:00 PM Eastern

SHF Holdings, Inc., through its subsidiaries, provides access to banking, lending, and other financial services to financial institutions serving the cannabis industry. The company, through its proprietary platform, offers access to business checking and savings accounts, cash management accounts, savings and investment options, commercial lending, courier services, remote deposit services, automated clearing house payments and origination, and wire payments. Its services allow cannabis related businesses to obtain services from financial institutions that allow them to run their business with enhanced financial insight into their business and access to resources. The company was founded in 2015 and is based in Golden, Colorado. SHF Holdings, Inc. operates as a subsidiary of Partner Colorado Credit Union.